AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 135 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $158,308,342 | -19.7% | 3,442,234 | +0.4% | 0.42% | -13.7% |
Q2 2023 | $197,060,608 | +55.2% | 3,428,930 | +1.2% | 0.49% | +52.8% |
Q1 2023 | $126,997,988 | +38.0% | 3,386,613 | +3.1% | 0.32% | +26.0% |
Q4 2022 | $92,023,760 | +0.3% | 3,284,217 | +0.6% | 0.25% | -5.6% |
Q3 2022 | $91,751,000 | -19.7% | 3,265,179 | -0.5% | 0.27% | -13.5% |
Q2 2022 | $114,214,000 | -8.8% | 3,282,967 | -5.9% | 0.31% | +9.9% |
Q1 2022 | $125,199,000 | +55.2% | 3,487,430 | +0.7% | 0.28% | +88.7% |
Q4 2021 | $80,684,000 | +22.5% | 3,464,335 | -0.0% | 0.15% | +20.0% |
Q3 2021 | $65,871,000 | -2.2% | 3,465,025 | +3.7% | 0.12% | -0.8% |
Q2 2021 | $67,364,000 | +6.8% | 3,341,501 | -2.9% | 0.13% | +3.3% |
Q1 2021 | $63,046,000 | -2.8% | 3,441,367 | +6.7% | 0.12% | -8.3% |
Q4 2020 | $64,873,000 | +26.3% | 3,225,883 | +17.7% | 0.13% | +10.8% |
Q3 2020 | $51,381,000 | -12.0% | 2,740,358 | +5.4% | 0.12% | -17.2% |
Q2 2020 | $58,398,000 | +51.3% | 2,600,107 | -0.0% | 0.14% | +28.3% |
Q1 2020 | $38,586,000 | +14.4% | 2,600,120 | +48.8% | 0.11% | +50.7% |
Q4 2019 | $33,717,000 | -2.7% | 1,747,907 | -0.0% | 0.08% | -11.8% |
Q3 2019 | $34,661,000 | +0.9% | 1,747,921 | +7.4% | 0.08% | +2.4% |
Q2 2019 | $34,365,000 | +14.2% | 1,627,903 | +10.5% | 0.08% | +12.2% |
Q1 2019 | $30,092,000 | +11.6% | 1,472,931 | +8.7% | 0.07% | 0.0% |
Q4 2018 | $26,973,000 | +9.8% | 1,355,451 | +6.2% | 0.07% | +29.8% |
Q3 2018 | $24,560,000 | +26.1% | 1,276,508 | -0.0% | 0.06% | 0.0% |
Q2 2018 | $19,480,000 | -1.0% | 1,276,552 | +21.6% | 0.06% | 0.0% |
Q1 2018 | $19,676,000 | -2.5% | 1,049,410 | +0.0% | 0.06% | 0.0% |
Q4 2017 | $20,190,000 | +7.7% | 1,049,395 | -0.0% | 0.06% | +5.6% |
Q3 2017 | $18,753,000 | +0.5% | 1,049,402 | +0.4% | 0.05% | 0.0% |
Q2 2017 | $18,667,000 | +23.2% | 1,045,188 | +0.0% | 0.05% | +25.6% |
Q1 2017 | $15,155,000 | -38.8% | 1,045,170 | -22.3% | 0.04% | -41.9% |
Q4 2016 | $24,769,000 | -12.1% | 1,344,684 | -9.4% | 0.07% | -8.6% |
Q3 2016 | $28,163,000 | +17.7% | 1,484,617 | 0.0% | 0.08% | +15.7% |
Q2 2016 | $23,932,000 | +34.3% | 1,484,617 | 0.0% | 0.07% | +27.3% |
Q1 2016 | $17,815,000 | -15.7% | 1,484,617 | 0.0% | 0.06% | -17.9% |
Q4 2015 | $21,126,000 | +21.9% | 1,484,617 | +0.2% | 0.07% | +19.6% |
Q3 2015 | $17,330,000 | -33.4% | 1,482,387 | +0.1% | 0.06% | -28.2% |
Q2 2015 | $26,022,000 | +17.0% | 1,480,178 | -0.4% | 0.08% | +14.7% |
Q1 2015 | $22,233,000 | +1169.7% | 1,486,153 | +885.8% | 0.07% | +1260.0% |
Q4 2014 | $1,751,000 | -73.8% | 150,760 | -73.7% | 0.01% | -77.3% |
Q3 2014 | $6,685,000 | – | 573,800 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Campbell & CO Investment Adviser LLC | 11,961 | $219,000 | 0.13% |
FEDERATED HERMES, INC. | 3,441,367 | $63,046,000 | 0.12% |
CORNERCAP INVESTMENT COUNSEL INC | 54,751 | $1,003,000 | 0.11% |
GSA CAPITAL PARTNERS LLP | 34,425 | $631,000 | 0.10% |
First Trust Direct Indexing L.P. | 11,913 | $218,000 | 0.06% |
Summit Global Investments | 47,546 | $871,000 | 0.06% |
WINTON GROUP Ltd | 49,766 | $912,000 | 0.05% |
FULLER & THALER ASSET MANAGEMENT, INC. | 397,950 | $7,290,000 | 0.05% |
AIGEN INVESTMENT MANAGEMENT, LP | 16,077 | $295,000 | 0.04% |
EXCHANGE TRADED CONCEPTS, LLC | 52,334 | $959,000 | 0.04% |